Bliss GVS Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE416D01022
  • NSEID: BLISSGVS
  • BSEID: 506197
INR
643.10
-21.8 (-3.28%)
BSENSE

Nov 20

BSE+NSE Vol: 3.88 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 730684,
    "name": "Bliss GVS Pharma",
    "stock_name": "Bliss GVS Pharma",
    "full_name": "Bliss GVS Pharma Ltd",
    "name_url": "stocks-analysis/bliss-gvs-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "643.10",
    "chg": -21.8,
    "chgp": "-3.28%",
    "dir": -1,
    "prev_price": "664.90",
    "mcapval": "7,090.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 506197,
    "symbol": "BLISSGVS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE416D01022",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "3.88 lacs",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/bliss-gvs-pharma-730684-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Bliss GVS Pharma Falls 4.44%: 4 Key Technical and Fundamental Factors This Week",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/bliss-gvs-pharma-falls-444-4-key-technical-and-fundamental-factors-this-week-4270633",
        "imagepath": "",
        "date": "2026-11-21 16:02:21",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Nov:</strong> Upgrade to Buy rating and bullish technical momentum shift</p>\n                    <p><strong>17 Nov:</strong> Mild price decline amid Sensex gains</p>\n                    <p><strong>18 Nov:</strong> Technical momentum moderates to mildly bullish</p>\n                    <p><strong>19 Nov:</strong> Mixed technical signals with bullish outlook</p>\n                    <p><strong>20 Nov:</strong> Sharp price drop on heavy volume closes week lower</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.673.00</div></div>\n                    <div clas..."
      },
      {
        "title": "Bliss GVS Pharma Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/bliss-gvs-pharma-ltd-technical-momentum-shifts-signal-bullish-outlook-4267483",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/BlissGVSPharmaL_technicaldot_4267483.png",
        "date": "2026-11-19 08:03:28",
        "description": "Bliss GVS Pharma Ltd has exhibited a notable shift in its technical momentum, with key indicators signalling an increasingly bullish trend. The stock’s recent upgrade from a Hold to a Buy rating, alongside improved moving averages and positive monthly MACD readings, suggests growing investor confidence in this small-cap pharmaceutical player amid a volatile market backdrop."
      },
      {
        "title": "Bliss GVS Pharma Ltd Technical Momentum Shifts Amid Strong Long-Term Returns",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/bliss-gvs-pharma-ltd-technical-momentum-shifts-amid-strong-long-term-returns-4265947",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/BlissGVSPharmaL_technicaldot_4265947.png",
        "date": "2026-11-18 08:03:15",
        "description": "Bliss GVS Pharma Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of mid-November 2026. This subtle change is reflected across key technical indicators including MACD, RSI, moving averages, and Bollinger Bands, suggesting a cautious but positive outlook for the small-cap pharmaceutical player amid a volatile market backdrop."
      },
      {
        "title": "Bliss GVS Pharma Upgraded to Buy on Strong Financials and Bullish Technicals",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/bliss-gvs-pharma-upgraded-to-buy-on-strong-financials-and-bullish-technicals-4263212",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/BlissGVSPharmaL_mojoScore_4263212.png",
        "date": "2026-11-16 08:17:12",
        "description": "Bliss GVS Pharma Ltd has been upgraded from a Hold to a Buy rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical outlook. The upgrade reflects the company’s robust quarterly results, improved technical indicators, and sustained market-beating returns, despite some valuation concerns and risks related to promoter share pledging."
      },
      {
        "title": "Bliss GVS Pharma Ltd Sees Bullish Momentum Shift Amid Strong Technical Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/bliss-gvs-pharma-ltd-sees-bullish-momentum-shift-amid-strong-technical-signals-4263053",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/BlissGVSPharmaL_technicaldot_4263053.png",
        "date": "2026-11-16 08:02:33",
        "description": "Bliss GVS Pharma Ltd has demonstrated a significant shift in price momentum, supported by a range of technical indicators signalling a bullish trend. The pharmaceutical small-cap stock has outperformed the broader market with a 4.97% gain on 16 Nov 2026, reflecting renewed investor confidence and a positive outlook for the sector."
      },
      {
        "title": "Bliss GVS Pharma Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/bliss-gvs-pharma-ltd-hits-upper-circuit-amid-strong-buying-pressure-4256890",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/BlissGVSPharmaL_stocks_hitting_upper_circuit_4256890.png",
        "date": "2026-11-09 11:00:11",
        "description": "At Rs 655.4, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bliss GVS Pharma Ltd locked at its upper circuit of 5% on 09 Nov 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Bliss GVS Pharma Ltd is Rated Hold by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/bliss-gvs-pharma-ltd-is-rated-hold-by-marketsmojo-4252034",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/BlissGVSPharmaL_mojoScore_4252034.png",
        "date": "2026-11-05 10:11:34",
        "description": "Bliss GVS Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 October 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 November 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Bliss GVS Pharma Ltd Locks at Upper Circuit With 3.22% Gain — Buyers Queue, Sellers Absent",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/bliss-gvs-pharma-ltd-hits-upper-circuit-amid-robust-buying-pressure-4251940",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/BlissGVSPharmaL_stocks_hitting_upper_circuit_4251940.png",
        "date": "2026-11-05 10:01:17",
        "description": "At Rs 639.5, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bliss GVS Pharma Ltd locked at its upper circuit of 3.22% on 5 Nov 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Bliss GVS Pharma Gains 3.17%: 2 Key Events Shaping the Week",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/bliss-gvs-pharma-gains-317-2-key-events-shaping-the-week-4245944",
        "imagepath": "",
        "date": "2026-10-31 16:02:09",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>26 Oct:</strong> Stock opens at Rs.617.15, down 1.81% despite Sensex rally</p>\n                    <p><strong>27 Oct:</strong> Strong rebound with 4.28% gain to Rs.643.55</p>\n                    <p><strong>29 Oct:</strong> Hits upper circuit at Rs.680.90 (+4.86%) amid robust buying</p>\n                    <p><strong>30 Oct:</strong> Hits lower circuit at Rs.646.90 (-5.00%) amid heavy selling</p>\n                    <p><strong>Week Close:</strong> Rs.648.40, net +3.17% vs Sensex +2.12%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.628.50</div></div>\n   ..."
      }
    ],
    "total": 141,
    "sid": "730684",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/bliss-gvs-pharma-730684"
  },
  "announcements": [
    {
      "caption": " Shareholder Meeting / Postal Ballot-Scrutinizer\"s Report",
      "datetime": "17-Nov-2026",
      "details": "Please find enclosed herewith the disclosure of voting results of the Postal Ballot Notice dated September 28 2026 through the remote e-voting process along with the Scrutinizers Report/",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot",
      "datetime": "17-Nov-2026",
      "details": "Please find enclosed herewith the Disclosure of Voting Result of the Postal Ballot Notice dated September 28 2026 through the remote e-voting process alongwith the Scrutinizers Report",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)",
      "datetime": "06-Nov-2026",
      "details": "Please find enclosed herewith the Intimation under Regulation 30 of the SEBI Listing Regulations.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bliss GVS Pharma Ltd has declared <strong>100%</strong> dividend, ex-date: 08 Jul 26",
          "dt": "2026-07-08",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Bliss GVS Pharma Ltd has announced <strong>1:10</strong> stock split, ex-date: 11 Mar 08",
          "dt": "2008-03-11",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Bliss GVS Pharma Ltd has announced <strong>3:5</strong> bonus issue, ex-date: 26 Sep 08",
          "dt": "2008-09-26",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

17-Nov-2026 | Source : BSE

Please find enclosed herewith the disclosure of voting results of the Postal Ballot Notice dated September 28 2026 through the remote e-voting process along with the Scrutinizers Report/

Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

17-Nov-2026 | Source : BSE

Please find enclosed herewith the Disclosure of Voting Result of the Postal Ballot Notice dated September 28 2026 through the remote e-voting process alongwith the Scrutinizers Report

Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)

06-Nov-2026 | Source : BSE

Please find enclosed herewith the Intimation under Regulation 30 of the SEBI Listing Regulations.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Bliss GVS Pharma Ltd has declared 100% dividend, ex-date: 08 Jul 26

stock-summary
SPLITS

Bliss GVS Pharma Ltd has announced 1:10 stock split, ex-date: 11 Mar 08

stock-summary
BONUS

Bliss GVS Pharma Ltd has announced 3:5 bonus issue, ex-date: 26 Sep 08

stock-summary
RIGHTS

No Rights history available